Trevena, Inc.

NasdaqCM:TRVN Stock Report

Market Cap: US$7.2m

Trevena Management

Management criteria checks 3/4

Trevena's CEO is Carrie Bourdow, appointed in Oct 2018, has a tenure of 5.5 years. total yearly compensation is $1.00M, comprised of 65.4% salary and 34.6% bonuses, including company stock and options. directly owns 0.51% of the company’s shares, worth $36.45K. The average tenure of the management team and the board of directors is 5.4 years and 9.8 years respectively.

Key information

Carrie Bourdow

Chief executive officer

US$1.0m

Total compensation

CEO salary percentage65.4%
CEO tenure5.5yrs
CEO ownership0.5%
Management average tenure5.4yrs
Board average tenure9.8yrs

Recent management updates

Recent updates

Trevena Q2 2022 Earnings Preview

Aug 10

Trevena slides on $2M preferred stock offering

Jul 29

Trevena (NASDAQ:TRVN) Will Have To Spend Its Cash Wisely

Jul 08
Trevena (NASDAQ:TRVN) Will Have To Spend Its Cash Wisely

Is Trevena (NASDAQ:TRVN) In A Good Position To Deliver On Growth Plans?

Mar 19
Is Trevena (NASDAQ:TRVN) In A Good Position To Deliver On Growth Plans?

Trevena Offers An Enticing Risk-Reward At These Prices

Dec 14

Trevena: Remaining Patient After A Disappointing Q2 Earnings

Aug 17

Trevena announces resumption of NIH-run trial for TRV734 in opioid use disorder

Jun 16

Trevena's OLINVYK Provides One Of The Most Compelling Growth Profiles

May 10

Trevena Investor Presentation - Slideshow

May 08

Trevena (TRVN) Investor Presentation - Slideshow

Nov 16

Trevena: Reaffirming A Buy On OLINVYK DEA Scheduling

Nov 09

DEA classifies Trevena's oliceridine, distribution to start in November

Oct 30

CEO Compensation Analysis

How has Carrie Bourdow's remuneration changed compared to Trevena's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$40m

Sep 30 2023n/an/a

-US$31m

Jun 30 2023n/an/a

-US$38m

Mar 31 2023n/an/a

-US$45m

Dec 31 2022US$1mUS$656k

-US$54m

Sep 30 2022n/an/a

-US$61m

Jun 30 2022n/an/a

-US$59m

Mar 31 2022n/an/a

-US$58m

Dec 31 2021US$2mUS$637k

-US$52m

Sep 30 2021n/an/a

-US$50m

Jun 30 2021n/an/a

-US$41m

Mar 31 2021n/an/a

-US$33m

Dec 31 2020US$3mUS$613k

-US$29m

Sep 30 2020n/an/a

-US$24m

Jun 30 2020n/an/a

-US$27m

Mar 31 2020n/an/a

-US$25m

Dec 31 2019US$2mUS$563k

-US$25m

Sep 30 2019n/an/a

-US$26m

Jun 30 2019n/an/a

-US$22m

Mar 31 2019n/an/a

-US$27m

Dec 31 2018US$2mUS$418k

-US$31m

Sep 30 2018n/an/a

-US$38m

Jun 30 2018n/an/a

-US$49m

Mar 31 2018n/an/a

-US$60m

Dec 31 2017US$1mUS$341k

-US$72m

Compensation vs Market: Carrie's total compensation ($USD1.00M) is above average for companies of similar size in the US market ($USD675.31K).

Compensation vs Earnings: Carrie's compensation has been consistent with company performance over the past year.

CEO

Carrie Bourdow (60 yo)

5.5yrs

Tenure

US$1,002,005

Compensation

Ms. Carrie L. Bourdow has been Chief Executive Officer, President and Director at Trevena, Inc. since October 01, 2018 and serves as its Chairman since November 09, 2023. Ms. Bourdow served as an Executive...

Leadership Team

NamePositionTenureCompensationOwnership
Carrie Bourdow
President5.5yrsUS$1.00m0.51%
$ 36.4k
Barry Shin
Executive VP4.8yrsUS$670.03k0.21%
$ 15.2k
Mark Demitrack
Senior VP & Chief Medical Officer5.9yrsUS$690.32k0.20%
$ 14.4k
Howard Rockman
Scientific Founderno datano datano data
Joel Solomon
VP, General Counsel & Chief Compliance Officerno datano datano data
Michael Catalano
Vice President of Marketing6.2yrsno datano data
Robert Yoder
Senior VP5.3yrsUS$689.16k0.12%
$ 8.3k
Patricia Drake
Senior VP & Chief Commercial Officer2.4yrsno data0.072%
$ 5.2k

5.4yrs

Average Tenure

57yo

Average Age

Experienced Management: TRVN's management team is seasoned and experienced (5.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Carrie Bourdow
President5.5yrsUS$1.00m0.51%
$ 36.4k
Howard Rockman
Scientific Founderno datano datano data
William Schmidt
Member of Scientific Advisory Boardno datano datano data
Jason Nunn
Independent Director10.8yrsUS$98.43k0.00093%
$ 66.6
John LaMattina
Member of the Scientific Advisory Board15.3yrsno datano data
Robert Lefkowitz
Member of Scientific Advisory Boardno datano datano data
Robert R. Ruffolo
Member of the Scientific Advisory Board15.3yrsno datano data
Mark H. Corrigan
Directorless than a yearno data0%
$ 0
Anne Phillips
Independent Director10.3yrsUS$98.43k0%
$ 0
Scott Braunstein
Lead Independent Director5.6yrsUS$85.93k0%
$ 0
Barbara Yanni
Independent Director9.8yrsUS$95.93k0%
$ 0
Marvin Johnson
Independent Director3.1yrsUS$83.43k0%
$ 0

9.8yrs

Average Tenure

69yo

Average Age

Experienced Board: TRVN's board of directors are considered experienced (9.8 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.